Wecare Probiotics Co., Ltd.
64
14
14
33
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 64 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 33 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (64)
Akk09 in Adults With Constipation
Role: lead
Probiotics for Constipation Relief in Adults
Role: lead
Probiotic Intervention in Constipation
Role: lead
Probiotic for Weight Management in Overweight and Obese Adults
Role: lead
Lactobacillus Gasseri and Hormonal Regulation in Obese Women
Role: lead
Probiotic Improve Constipation
Role: lead
Effect of Probiotics on Mycoplasma Pneumoniae Pneumonia
Role: lead
Probiotics in Obesity Management
Role: lead
Research on Probiotics in Improving Obesity
Role: lead
Probiotics Regulate Intestinal Health and Alleviate Anxiety
Role: lead
Weizmannia Coagulans BC99 Relieves Exercise-induced Fatigue
Role: lead
Sports Nutrition Benefits of Weizmannia Coagulans BC99
Role: lead
Effects of BLa80 and LRa05 on the Gut Microbiota Metabolite Profile of Healthy Individuals
Role: lead
Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects
Role: lead
Effectiveness of Probiotics in Relieving Allergic Rhinitis in Children
Role: lead
The Effect of Probiotics on the Improvement of Intestinal and Immune Function
Role: lead
the Role of Probiotic in Protein Metabolism
Role: lead
Probiotics' Effects on Hormones, Body and Mood in Obese Women
Role: lead
Weight Loss Effect of Akkermansia Muciniphila in Obese Patients
Role: lead
Probiotics for Alleviating Chronic Constipation in Adults
Role: lead